American Society of Ketamine Physicians - 2019 ASKP Annual Conference

Thu, September 19 2019, 6:00 PM - Sat, September 21 2019, 5:00 PM [MST]

6700 North Gaylord Rockies Boulevard, Aurora, CO, 80019, United States

Register Now

1. Select Seats

2. Review and Proceed

There are no registration options available. Please contact organizer for more details


Enter your discount code

  • Fee
  • Total amount

Thu, September 19 2019, 6:00 PM - Sat, September 21 2019, 5:00 PM [MST]

Gaylord Rockies Resort & Convention Center, 6700 North Gaylord Rockies Boulevard, Aurora, CO, 80019, United States.

This is the second annual conference for the American Society of Ketamine Physicians.  A conference involving multi-disciplinary speakers discussing ketamine use for mood disorders, psychotherapy and pain conditions.   Please join us for this educational conference and extraordinary networking experience. 
This conference is sure to sell out so be sure to register soon!





SEPTEMBER 20th and 21st






6:30-8:30pm - ASKP Meet and Greet Event




8:00am – 9:00am – Breakfast, coffee, registration

9:00am - 9:30am – Steven Mandel, M.D.

            “Ketamine Infusion Therapy for Mood Disorders- Yesterday, Today, and Tomorrow”

9:30am – 10:25am – Sanjay Mathew, M.D.

“Ketamine for Treatment-Resistant Depression: Where Does it Fit?”

10:25am – 11:20am – Lori Calabrese, M.D.

“Real World Results:  When Ketamine Stops Suicide”

11:20am – 11:30am – Morning Break with snack

11:30am – 12:25pm – Gerard Sanacora, M.D., Ph.D.

“Lessons Learned from Phase 2 and 3 Clinical Trials With Esketamine”

12:25pm – 1:20pm – Amit Anand, M.D.

"Comparative Effectiveness of Ketamine for Treatment Resistant Depression"

1:20pm – 2:10 pm – Lunch

2:10pm – 3:05pm – Rachel Dalthorp, M.D.

“Hormone Disruption in Ketamine Treatment”

3:05pm – 4:00pm – Daniel Richman, M.D.

“IV Ketamine for CRPS (Complex Regional Pain Syndrome)”

4:00pm – 4:10pm – Afternoon Break

4:10pm – 5:10pm – Jessica Katzman, Psy.D.

“Rapid Depression Remission and the ‘Therapeutic Bends’”








7:45 am – 8:30 am – Breakfast

8:30am-10:40am – Break Out Sessions





























10:40am – 10:50am – Morning Break

10:50am – 11:45am – Omid J. Naim, M.D.

“An Integrative Approach to Psychedelic Therapy: Promoting Transformation and Community in the Healing Process”

11:45am – 12:40pm – David Sheehan, M.D.

“Suicidality: Assessment, Documentation and Pharmacological Treatment”

12:40pm – 1:30pm – Lunch

1:30pm – 2:25pm – Jeffrey Becker, M.D.

Discussing fMRI findings in ketamine treatment

2:25pm – 3:20pm – Jennifer Winegarden, D.O.

“Ketamine in Refractory Cancer Pain:  Changing the Course of End-of-Life Treatment”

3:20pm – 3:30pm – Afternoon Break

3:30pm –5:00pm – Lightening Abstracts

Ketamine for Anxiety             Dr. Michael Banov

Ketamine and PMDD                        Cassandra Gentry

Combination Therapy


Ketamine and TMS               Dr. Cindy McKinzie & Melanie Dillon


Accreditation and Designation Statements 2019 ASKP Conference

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and American Society of Ketamine Physicians. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.  The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 14 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 Disclosures Report: 


American Society of Ketamine Physicians

The American Society of Ketamine Physicians is a group of professionals dedicated to the safe clinical use of ketamine for mental health disorders and pain conditions. To get involved or apply for membership, please visit


Lori Calabrese, MD was educated at The Johns Hopkins University School of Medicine, completed residency training at Massachusetts General Hospital/Harvard Medical School. She served as clinical faculty at MGH/Harvard Medical School and as Clinical Assistant Professor of Psychiatry at Yale. She loves patient care, and has worked in private practice in the Hartford area for more than 20 years. Dr. Calabrese was the first physician in CT to offer IV ketamine infusions for treatment resistant depression in her practice, Innovative Psychiatry, as part of a full array of psychiatric treatment options in an office setting. She has a keen interest in treating acute and chronic suicidal ideation with ketamine infusions. In 2018, she presented preliminary data using IV ketamine to treat suicidal outpatients in psychiatric private practice at the First International Conference for Ketamine and Related Compounds for Psychiatric Disorders in Oxford, UK. She has presented the results of her ongoing work using serial, titrated ketamine infusions for suicidal ideation at KRIYA Conference 2018 in San Francisco, California, at the 6th World Congress on Mental Health, Psychiatry and Wellbeing 2019 in New York, and at the APA 2019 Annual Meeting in San Francisco. She will also be speaking at the 2019 International Summit on Suicide Research in Miami in October, 2019.

Dr. Jennifer Winegarden, D.O., M.S. graduated from Michigan State University College of Osteopathic Medicine and is board certified in Family Medicine and Hospice and Palliative Medicine. She holds a master’s degree in Pain Research, Education and Policy from Tufts University. She has been committed to full-time work in hospice medicine for the last 11 years and acted as the Chief Medical Officer of The Medical Team Hospice for the past 5 years. She has extended education in the field of neurology and pharmacology which has fueled her interest in the treatment of pain, and the use of adjuvant pain medications. This has included significant research in the use of non-opioid medications, particularly ketamine, to better control pain while reducing the need for opioid medications.
Gerard Sanacora, PhD, MD
George D. and Esther S. Gross Professor of Psychiatry; Director, Yale Depression Research Program; Co-Director, Yale New Haven Hospital Interventional Psychiatry Service

Dr. Sanacora is currently an Associate Professor and the Director of the Yale Depression Research Program. Dr. Sanacora’s work is concentrated largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders. Much of his recent research has focused on identifying the contributions of the amino acid neurotransmitter systems (GABA and Glutamate) to the neurobiology of mood disorders and the mechanism of antidepressant action.
Steven Mandel, MD
Founder and President

Steven L. Mandel, M.D. is the founder and president of Ketamine Clinics of Los Angeles. He is also a founder and first president of ASKP. He is a board-certified anesthesiologist with a master’s degree in psychology. He has been practicing medicine for over 35 years. Dr. Mandel is an internationally recognized pioneer in the use of IV Ketamine Infusion Therapy for the treatment of depression, suicidality, other mood disorders, and chronic pain conditions. He has appeared on television, radio, podcasts, and been interviewed by numerous publications including The Doctors, CBS, PBS, VICE, Inc Magazine, BuzzFeed, Wired, LA Magazine, and more. Dr. Mandel has personally administered over 8,500 infusions since opening Ketamine Clinics Los Angeles in 2014. When he isn't caring for patients, Dr. Mandel enjoys spending time with his wife of 33 years, their four children, dog Magellan; aboard a sailboat or on skis at the top of a mountain.
Amit Anand, MD
Professor of Medicine at the Cleveland Clinic Lerner College of Medicine

Professor of Medicine at the Cleveland Clinic Lerner College of Medicine; Vice-chair for Research for the Center for Behavioral Health; Director, Mood and Emotional Disorders Across the Life Span (MEDALS) program, Cleveland Clinic
Jeffrey Becker, MD
Adult Psychiatry and Wellness

Dr. Jeffrey Becker trained at UCLA/NPI in both Medicine and Psychiatry with a focus on Neuropsychiatry and Functional Medicine. He is board-certified through the American Board of Psychiatry and Neurology (ABPN) and the American Board for Integrative and Holistic Medicine (ABIHM). He maintains clinical offices in Los Angeles and Santa Barbara and is affiliated with UCLA/NPI as Volunteer Clinical Faculty. Dr. Becker’s integrative and holistic approach to psychiatry examines mind and brain function in reference to the health of the whole body. He combines conventional medicine with evidence-based nutrients, lifestyle modifications, and complimentary treatments to restore synergy and balance to baseline physiology. Clinical presentation, past medical history, laboratory results and genetic studies are examined to customize an individualized treatment plan designed specifically to promote optimal health and improve medical and psychiatric outcomes for each patient.
Rachel Dalthorp M.D.
Diplomate American Board of Psychiatry and Neurology

Dr. Rachel Dalthorp received her medical degree from the University of Oklahoma College of Medicine in 2010 followed by a a four-year psychiatric residency where she focused on developing expertise in the sub-specialty of reproductive psychiatry. She owns a private practice in the Oklahoma City area called Balance Women’s Health. In 2015 she developed an interest in interventional treatments for psychiatric disorders, specifically treatment resistant depression, and began providing ketamine infusion therapy. Dr. Dalthorp has provided more than 4000 infusions. Her expertise in hormone related mood disorders and experience treating patients with Ketamine infusions led to an interest in understanding how hormones might impact infusion results and efforts to modify treatment to improve response rates.
Jessica Katzman, Psy.D
Clinical Psychologist

Dr. Jessica Katzman, Psy.D. is a Clinical Psychologist licensed in California. She co-founded Healing Realms, a center for depth-oriented ketamine assisted psychotherapy, with Dr. Robert Grant in 2017, following an advanced training in therapeutic ketamine with the KRIYA Institute. She also organizes a local consultation group for ketamine assisted psychotherapy providers in the Bay Area. Dr. Katzman has 20 years of experience as a therapist and supervisor, including a decade providing harm reduction and disability evaluation services in a community mental health setting. In her private practice, she specializes in mood and anxiety disorders, chronic and complex PTSD, addressing alcohol and substance use from a harm reduction lens, supporting the LGBTQ community, assessments for gender transition procedures, and assisting those integrating psychedelic experiences.

Vice Chair for Research; Baylor College of Medicine; Professor of Psychiatry and Behavioral Sciences; Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Chair for Research in Psychiatry; Menninger Department of Psychiatry & Behavioral Sciences; Baylor College of Medicine; Houston, TX, US; Director; Mood and Anxiety Disorders Program; Baylor College of Medicine; Houston, Texas, United States; Staff Physician; Michael E. DeBakey VA Medical Center;
Daniel Richman, MD
Anesthesiologist and Pain Management Physician

Attending Anesthesiologist and Pain Management Physician - Hospital for Special Surgery Assistant Attending and Clinical Instructor - Tri-Institutional Pain Management Fellowship, New York-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.
Omid J Naim, M.D.
Founder & Director, Psychiatry

As the founder of La Maida Institute, Omid is proud to share his vision of a “communal model for preventive health.” On a day-to-day basis, he moves between seeing patients in his clinic, Hope Integrative Psychiatry, and serving as the creative director of La Maida, supporting its growth and development through collaboration and teamwork.
David Sheehan, M.D., M.B.A.
Distinguished University Health Professor Emeritus

David V. Sheehan M.D., M.B.A. is recognized as one of the world’s leading researchers in anxiety disorders. He has written over 500 abstracts and 300 publications including a bestseller The Anxiety Disease.

Photo Gallery